| http://dbpedia.org/ontology/abstract
|
JWH-073 ist eine synthetische chemische Ve … JWH-073 ist eine synthetische chemische Verbindung aus der Gruppe der Alkylindol-Derivate und wurde von John W. Huffman entwickelt. Es wirkt als Partialagonist am CB1 und mit etwa 5-fach höherer Selektivität am CB2-Rezeptor. Es zeigt unter anderem analgetische Eigenschaften. Dieses Cannabinoid wurde als zugesetzter Wirkstoff in Produkten gefunden, die von den Herstellern als „Kräutermischungen“ etwa unter der Bezeichnung „Spice“ oder in ähnlichen Produkten vertrieben wurden. JWH-073 hat nach Auffassung des Sachverständigenausschusses für Betäubungsmittel in Deutschland eine stärkere Wirkung als THC.Deutschland eine stärkere Wirkung als THC.
, JWH-073 – organiczny związek chemiczny, syntetyczny kanabinoid otrzymany przez Johna W. Huffmana (stąd akronim JWH). W Polsce od 2010 roku jest w grupie I-N Ustawy o przeciwdziałaniu narkomanii.
, JWH-073, a synthetic cannabinoid, is an an … JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5x the affinity at CB2. The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound. On 20 April 2009, JWH-073 was claimed by researchers at the University of Freiburg to have been found in a "fertiliser" product called "Forest Humus", along with another synthetic cannabinoid (C8)-CP 47,497. These claims were confirmed in July 2009 when tests of Spice product, seized after the legal ban on JWH-018 had gone into effect in Germany, were shown to contain the unregulated compound JWH-073 instead. The analgesic effects of cannabinoid ligands, mediated by CB1 receptors are well established in treatment of neuropathic pain, as well as cancer pain and arthritis. These compounds work by mimicking the body's naturally-produced endocannabinoid hormones such as 2-arachidonoylglycerol and anandamide, which are biologically active and can exacerbate or inhibit nerve signaling. As the cause is poorly understood in chronic pain states, more research and development must be done before we can realize the therapeutic potential of this class of biologic compounds.ntial of this class of biologic compounds.
|
| http://dbpedia.org/ontology/casNumber
|
208987-48-8
|
| http://dbpedia.org/ontology/fdaUniiCode
|
BBX3BP2772
|
| http://dbpedia.org/ontology/pubchem
|
10471670
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/JWH073.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
16564159
|
| http://dbpedia.org/ontology/wikiPageLength
|
10246
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1060041294
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Synthetic_cannabinoid +
, http://dbpedia.org/resource/CP_47%2C497 +
, http://dbpedia.org/resource/Spice_%28drug%29 +
, http://dbpedia.org/resource/Controlled_Substances_Act +
, http://dbpedia.org/resource/Analgesic +
, http://dbpedia.org/resource/Naphthoylindole +
, http://dbpedia.org/resource/Category:CB1_receptor_agonists +
, http://dbpedia.org/resource/Category:CB2_receptor_agonists +
, http://dbpedia.org/resource/Category:Naphthoylindoles +
, http://dbpedia.org/resource/HU-210 +
, http://dbpedia.org/resource/Food_and_Drug_Administration_Safety_and_Innovation_Act +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/JWH-019 +
, http://dbpedia.org/resource/JWH-018 +
, http://dbpedia.org/resource/JWH-081 +
, http://dbpedia.org/resource/Cannabinoid +
, http://dbpedia.org/resource/MEPIRAPIM +
, http://dbpedia.org/resource/Anandamide +
, http://dbpedia.org/resource/Category:JWH_cannabinoids +
, http://dbpedia.org/resource/University_of_Freiburg +
, http://dbpedia.org/resource/Tetrahydrocannabinol +
, http://dbpedia.org/resource/Drug_Enforcement_Administration +
, http://dbpedia.org/resource/John_W._Huffman +
, http://dbpedia.org/resource/File:Jwh-073.JPG +
, http://dbpedia.org/resource/File:4%27-methyl-JWH-073_structure.png +
, http://dbpedia.org/resource/Standard_for_the_Uniform_Scheduling_of_Medicines_and_Poisons +
, http://dbpedia.org/resource/2-arachidonoylglycerol +
|
| http://dbpedia.org/property/c
|
23
|
| http://dbpedia.org/property/casNumber
|
208987
|
| http://dbpedia.org/property/chemspiderid
|
8647081
|
| http://dbpedia.org/property/h
|
21
|
| http://dbpedia.org/property/iupacName
|
Naphthalen-1-yl-methanone
|
| http://dbpedia.org/property/legalCa
|
Schedule II
|
| http://dbpedia.org/property/legalDe
|
Anlage II
|
| http://dbpedia.org/property/legalStatus
|
Illegal in Latvia & Poland
|
| http://dbpedia.org/property/legalUk
|
Class B
|
| http://dbpedia.org/property/legalUs
|
Schedule I
|
| http://dbpedia.org/property/n
|
1
|
| http://dbpedia.org/property/o
|
1
|
| http://dbpedia.org/property/pubchem
|
10471670
|
| http://dbpedia.org/property/smiles
|
CCCCN1C=CCC3=CC=CC4=CC=CC=C43
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
VCHHHSMPMLNVGS-UHFFFAOYSA-N
|
| http://dbpedia.org/property/unii
|
BBX3BP2772
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
451057329
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:See_also +
, http://dbpedia.org/resource/Template:Clear-left +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Cannabinoidergics +
, http://dbpedia.org/resource/Template:Cannabinoids +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Hallucinogens +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:CB1_receptor_agonists +
, http://dbpedia.org/resource/Category:CB2_receptor_agonists +
, http://dbpedia.org/resource/Category:JWH_cannabinoids +
, http://dbpedia.org/resource/Category:Naphthoylindoles +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Chemical +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/JWH-073?oldid=1060041294&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Jwh-073.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/JWH073.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/4%27-methyl-JWH-073_structure.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/JWH-073 +
|
| owl:sameAs |
http://de.dbpedia.org/resource/JWH-073 +
, http://sh.dbpedia.org/resource/JWH-073 +
, http://fi.dbpedia.org/resource/JWH-073 +
, http://rdf.freebase.com/ns/m.03ybccy +
, http://yago-knowledge.org/resource/JWH-073 +
, https://global.dbpedia.org/id/3vScK +
, http://pl.dbpedia.org/resource/JWH-073 +
, http://sr.dbpedia.org/resource/JWH-073 +
, http://dbpedia.org/resource/JWH-073 +
, http://hr.dbpedia.org/resource/JWH-073 +
, http://www.wikidata.org/entity/Q423476 +
|
| rdf:type |
http://dbpedia.org/class/yago/Abbreviation107091587 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/WikicatKetones +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/Naphthalene114958564 +
, http://dbpedia.org/class/yago/Hydrocarbon114911057 +
, http://dbpedia.org/class/yago/WikicatNaphthalenes +
, http://dbpedia.org/ontology/ChemicalCompound +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/Form106290637 +
, http://dbpedia.org/class/yago/Ketone114926294 +
, http://dbpedia.org/class/yago/LanguageUnit106284225 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/WikicatAromaticKetones +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/WikicatAbbreviations +
, http://dbpedia.org/class/yago/Word106286395 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Relation100031921 +
|
| rdfs:comment |
JWH-073 ist eine synthetische chemische Ve … JWH-073 ist eine synthetische chemische Verbindung aus der Gruppe der Alkylindol-Derivate und wurde von John W. Huffman entwickelt. Es wirkt als Partialagonist am CB1 und mit etwa 5-fach höherer Selektivität am CB2-Rezeptor. Es zeigt unter anderem analgetische Eigenschaften. unter anderem analgetische Eigenschaften.
, JWH-073 – organiczny związek chemiczny, syntetyczny kanabinoid otrzymany przez Johna W. Huffmana (stąd akronim JWH). W Polsce od 2010 roku jest w grupie I-N Ustawy o przeciwdziałaniu narkomanii.
, JWH-073, a synthetic cannabinoid, is an an … JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5x the affinity at CB2. The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound. The analgesic effects of cannabinoid ligands, mediated by CB1 receptors are well established in treatment of neuropathic pain, as well as cancer pain and arthritis.ain, as well as cancer pain and arthritis.
|
| rdfs:label |
JWH-073
|
| rdfs:seeAlso |
http://dbpedia.org/resource/JWH-018 +
|
